EP4159204
NÝ LYFJASAMSETNING
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.12.2011EP published:
14.2.2024EP application number:
22209104.3
EP translation filed:
16.4.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
19.12.2031Expiry date:
19.12.2026Next due date:
31.12.2026
Title in English:
NOVEL PHARMACEUTICAL COMPOSITIONLanguage of the patent:
English
Timeline
Today
20.12.2011EP application
14.2.2024EP Publication
16.4.2024Translation submitted
15.6.2024Registration published
19.12.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
DEMARIN, Douglas, J.Address:
Collegeville, PA, 19426, US
Name:
LE, Ngocdiep T.Address:
Collegeville, PA, 19426, US
Name:
HENRIQUEZ, FranciscoAddress:
Collegeville, PA, 19426, US
Name:
WANG, LihongAddress:
Collegeville, PA, 19426, US
Agent
Name:
COSMOVICI INTELLECTUAL PROPERTY SARLAddress:
11 Boulevard Sébastopol, FR
Priority
Number:
201061424967 PDate:
20.12.2010Country:
US
Classification
Categories:
A61K 9/28, A61K 9/20, A61K 31/519, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 28.11.2024
Expires: 19.12.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 19.12.2025
Expires: 19.12.2026
Payer: Árnason Faktor ehf.